查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1483674

神經血管血栓切除設備市場 - 全球規模、佔有率、趨勢分析、機會、預測報告，2019-2030

Neurovascular Thrombectomy Devices Market - Global Size, Share, Trend Analysis, Opportunity and Forecast Report, 2019-2030, Segmented By Device Type; By Indication; By End User; By Region
出版日期: | 出版商: Blueweave Consulting | 英文 400 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

神經血管取栓設備的全球市場規模預計將以 6.88%的年複合成長率大幅擴張，到2030年將達到 40.8 億美元

由於人們對中風治療和管理的認知不斷提高、中風盛行率不斷上升以及對改進診斷的日益關注，神經血管血栓切除設備的全球市場蓬勃發展。

領先的策略諮詢和市場研究公司 BlueWeave Consulting 在最近的一項研究中估計，2023年全球神經血管血栓切除設備市場規模為 21.7 億美元。 BlueWeave 預測，在2024年至2030年的預測期內，全球神經血管血栓切除設備市場規模將以 6.88%的年複合成長率成長，到2030年將達到 40.8 億美元。神經血管疾病的盛行率不斷上升以及對有效治療方案的需求不斷成長是全球神經血管血栓切除設備市場成長的主要驅動力。此外，在分析期間，由於介入神經學領域研發活動的擴展，預計市場將發現利潤豐厚的機會。

機會- 增加獲得醫療設施的機會

神經血管血栓切除設備的全球市場依最終用戶分為醫院、門診手術中心、專科診所等。醫院細分市場佔據最大的市場佔有率，主要是由於大量的新生血管疾病患者到醫院就各種病症進行診斷和治療。特別是在印度和中國等新興國家，由於醫療基礎設施的成長，醫院數量不斷增加，預計在分析期間將推動全球神經血管血栓切除設備市場的醫院領域。

地緣政治緊張局勢加劇對神經血管血栓切除設備全球市場的影響

地緣政治緊張局勢的加劇阻礙了全球神經血管血栓切除設備市場的成長。2022年2月開始的俄烏戰爭突然給烏克蘭衛生部門帶來了巨大壓力，造成了前所未有的困難。炸彈摧毀了建築物並擾亂了醫療服務的提供。缺乏醫護人員的幫助阻礙了常規預防性檢查，導致神經血管疾病的診斷率較低。巴勒斯坦的醫療機構也面臨類似的情況，這直接影響了對神經血管血栓切除設備的需求，並限制了這些地區的市場成長。

神經血管血栓切除裝置的全球市場

依細分市場分類的覆蓋範圍

神經血管血栓切除裝置的全球市場—依適應症分類

根據適應症，全球神經血管血栓切除設備市場分為缺血性中風、出血性中風等。由於缺血性中風在全球範圍內的高盛行率，其在全球神經血管血栓切除設備市場中佔最高佔有率。根據世界中風組織的資料，缺血性中風佔全球整體中風病例的62%以上。對先進神經血管血栓切除設備開發的日益關注和投資預計將為市場參與企業提供利潤豐厚的成長機會。

神經血管血栓切除裝置的全球市場 – 依地區

關於神經血管血栓切除裝置全球市場的詳細研究報告涵蓋了五個主要地區的眾多各國市場。北美、歐洲、亞太地區、拉丁美洲和中東非洲。北美主導全球神經血管血栓切除設備市場。神經血管疾病負擔的增加、醫療保健支出的增加以及門診醫療設施數量的增加直接影響北美市場的成長。此外，針對各種神經血管疾病的優惠償付政策也促進了北美神經血管血栓切除設備市場的成長。

競爭格局

在全球神經血管血栓切除設備市場中營運的主要企業包括Acandis GmbH、Penumbra, Inc.、Medtronic、VESALIO, LLC、Johnson &Johnson、MicroVention, Inc.、Phenox GmbH、Imperative Care, Inc.、Balt Group、NeuroVasc Technologies, Inc.。

為了進一步增加市場佔有率，這些公司採取各種策略，例如併購、合作、合資、授權合約和新產品發布。

本報告的詳細分析涵蓋了全球神經血管血栓切除設備市場的成長潛力、未來趨勢和資訊。還涵蓋了推動市場總規模預測的因素。本報告致力於提供全球神經血管血栓切除設備市場的最新技術趨勢以及產業見解，以幫助決策者做出明智的策略決策。此外，也分析市場成長動力、挑戰和競爭對手。

目錄

第1章 研究框架

第2章 執行摘要

第3章 全球神經血管血栓切除設備市場洞察

  • 產業價值鏈分析
  • DROC分析
    • 生長促進因子
      • 中風發生率上升
      • 人口老化加劇
      • 提高認知並改善診斷
      • 優惠償付政策
    • 抑制因素
      • 設備高成本
      • 有限的醫療專業知識
      • 嚴格的監管要求
    • 機會
      • 技術進步
      • 新興市場
      • 專注微創手術
    • 課題
      • 保持程序效率
      • 許多國家的償付挑戰
      • 競爭加劇
  • 科技進步/最新發展
  • 法律規範
  • 波特五力分析

第4章 全球神經血管血栓切除設備市場：行銷策略

第5章 全球神經血管血栓切除設備市場概述

  • 2019-2030年市場規模及預測
    • 按金額
  • 市場佔有率及預測
    • 依設備類型
      • 吸引裝置
      • 支架取出裝置
      • 機械取栓裝置
      • 吸引裝置
      • 其他
    • 按適應症
      • 缺血性中風
      • 出血性中風
      • 其他
    • 依最終用戶
      • 醫院
      • 門診手術中心
      • 專科診所
      • 其他
    • 依地區
      • 北美洲
      • 歐洲
      • 亞太地區
      • 拉丁美洲（LATAM）
      • 中東、非洲

第6章 北美神經血管血栓切除設備市場

  • 2019-2030年市場規模及預測
    • 按金額
  • 市場佔有率及預測
    • 依設備類型
    • 按適應症
    • 依最終用戶
    • 依國家/地區
      • 美國
      • 加拿大

第7章 歐洲神經血管血栓切除設備市場

  • 2019-2030年市場規模及預測
    • 按金額
  • 市場佔有率及預測
    • 依設備類型
    • 按適應症
    • 依最終用戶
    • 依國家/地區
      • 德國
      • 英國
      • 義大利
      • 法國
      • 西班牙
      • 比利時
      • 俄羅斯
      • 荷蘭
      • 歐洲其他地區

第8章 亞太神經血管血栓切除設備市場

  • 2019-2030年市場規模及預測
    • 按金額
  • 市場佔有率及預測
    • 依設備類型
    • 按適應症
    • 依最終用戶
    • 依國家/地區
      • 中國
      • 印度
      • 日本
      • 韓國
      • 澳洲和紐西蘭
      • 印尼
      • 馬來西亞
      • 新加坡
      • 越南
      • 其他亞太地區

第9章 拉丁美洲神經血管血栓切除設備市場

  • 2019-2030年市場規模及預測
    • 按金額
  • 市場佔有率及預測
    • 依設備類型
    • 按適應症
    • 依最終用戶
    • 依國家/地區
      • 巴西
      • 墨西哥
      • 阿根廷
      • 秘魯
      • 其他拉丁美洲

第10章 中東與非洲神經血管血栓切除設備市場

  • 2019-2030年市場規模及預測
    • 按金額
  • 市場佔有率及預測
    • 依設備類型
    • 按適應症
    • 依最終用戶
    • 依國家/地區
      • 沙烏地阿拉伯
      • 阿拉伯聯合大公國
      • 卡達
      • 科威特
      • 南非
      • 奈及利亞
      • 阿爾及利亞
      • 中東和非洲其他地區

第11章 競爭格局

  • 主要參與企業及其產品列表
  • 2023年全球神經血管血栓切除設備市場佔有率分析
  • 透過管理參數進行競爭基準化分析
  • 重大策略發展（合併、收購、聯盟等）

第12章 地緣政治緊張局勢加劇對全球神經血管血栓切除設備市場的影響

第13章 公司簡介（公司簡介、財務矩陣、競爭格局、關鍵人員、主要競爭對手、聯絡方式、策略展望、SWOT分析）

  • Acandis GmbH
  • Penumbra, Inc.
  • Medtronic
  • VESALIO, LLC
  • Johnson and Johnson
  • MicroVention, Inc.
  • Phenox GmbH
  • Imperative Care, Inc.
  • Balt Group
  • NeuroVasc Technologies, Inc.
  • Baylis Medical Company, Inc.
  • Boston Scientific Corporation
  • Terumo Corporation
  • Spectranetics Corporation
  • Edwards Lifesciences Corporation
  • Argon Medical Devices, Inc
  • Teleflex Incorporated
  • 其他主要企業

第14章 主要策略建議

第15章 調查方法

簡介目錄
Product Code: BWC24305

Global Neurovascular Thrombectomy Devices Market Size Set to Expand at Significant CAGR of 6.88% to Reach USD 4.08 Billion by 2030

Global Neurovascular Thrombectomy Devices Market is flourishing because of growing awareness about the treatment and management of stroke, rising prevalence of stroke, and an increasing focus on improved diagnosis.

BlueWeave Consulting, a leading strategic consulting and market research firm, in its recent study, estimated the Global Neurovascular Thrombectomy Devices Market size at USD 2.17 billion in 2023. During the forecast period between 2024 and 2030, BlueWeave expects the Global Neurovascular Thrombectomy Devices Market size to expand at a CAGR of 6.88% reaching a value of USD 4.08 billion by 2030. The growing incidence of neurovascular illnesses and the expanding need for efficient treatment options are key drivers of growth for the Global Neurovascular Thrombectomy Devices Market. Furthermore, during the period in analysis, the market is expected to witness lucrative opportunities due to the expansion of research and development activities in the field of interventional neurology.

Opportunity - Rising accessibility to healthcare facilities

The Global Neurovascular Thrombectomy Devices Market is segmented into hospitals, ambulatory surgical centers, specialty clinics, and others, based on end user. The hospitals segment holds the largest market share, mainly due to the high number of patients with neovascular diseases approaching hospitals for the diagnosis and treatment of various conditions. The increasing number of hospitals, particularly in emerging economies, such as India and China, owing to healthcare infrastructure growth, is anticipated to drive the hospital segment in the Global Neurovascular Thrombectomy Devices Market during the period in analysis.

Impact of Escalating Geopolitical Tensions on Global Neurovascular Thrombectomy Devices Market

The escalating geopolitical tensions hindered the growth of Global Neurovascular Thrombectomy Devices Market. The Russia-Ukraine war, began in February 2022, abruptly put the Ukraine's healthcare sector under tremendous strain and presented unprecedented difficulties. Bombs destroyed buildings and interfered with the delivery of healthcare services. Routine preventive checkups were hindered due to the inaccessibility of healthcare professionals, which resulted in a decline in the diagnosis rate of neurovascular diseases. In Palestine, healthcare facilities have been facing a similar situation, which directly impacts the demand for neurovascular thrombectomy devices, limiting its market growth in these regions.

Global Neurovascular Thrombectomy Devices Market

Segmental Coverage

Global Neurovascular Thrombectomy Devices Market - By Indication

Based on the indication, the Global Neurovascular Thrombectomy Devices Market is segmented into ischemic stroke, hemorrhagic stroke, and others. The ischemic stroke segment accounts for the highest share in the Global Neurovascular Thrombectomy Devices Market owing to its high prevalence worldwide. According to the World Stroke Organization, ischemic strokes account for more than 62% of all stroke incidents globally. The rising focus and investments to develop advanced neurovascular thrombectomy devices is expected to provide lucrative growth opportunities to the market players.

Global Neurovascular Thrombectomy Devices Market - By Region

The in-depth research report on the Global Neurovascular Thrombectomy Devices Market covers a number of country-specific markets across five major regions: North America, Europe, Asia Pacific (APAC), Latin America, and Middle East and Africa. North America dominates the Global Neurovascular Thrombectomy Devices Market. The increasing burden of neurovascular diseases, rising expenditure in healthcare, and growth in ambulatory care facilities are directly influencing the growth of the market in North America. Furthermore, favorable reimbursement policies for various neurovascular conditions also contribute to the growth of the Neurovascular Thrombectomy Devices Market in North America.

Competitive Landscape

Major players operating in the Global Neurovascular Thrombectomy Devices Market include Acandis GmbH, Penumbra, Inc., Medtronic, VESALIO, LLC, Johnson & Johnson, MicroVention, Inc., Phenox GmbH, Imperative Care, Inc., Balt Group, NeuroVasc Technologies, Inc., Baylis Medical Company, Inc., Boston Scientific Corporation, Terumo Corporation, Spectranetics Corporation, Edwards Lifesciences Corporation, Argon Medical Devices, Inc., and Teleflex Incorporated.

To further enhance their market share, these companies employ various strategies, including mergers and acquisitions, partnerships, joint ventures, license agreements, and new product launches.

The in-depth analysis of the report provides information about growth potential, upcoming trends, and the Global Neurovascular Thrombectomy Devices Market. It also highlights the factors driving forecasts of total market size. The report promises to provide recent technology trends in the Global Neurovascular Thrombectomy Devices Market and industry insights to help decision-makers make sound strategic decisions. Furthermore, the report also analyzes the growth drivers, challenges, and competitive dynamics of the market.

Table of Contents

1. Research Framework

  • 1.1. Research Objective
  • 1.2. Product Overview
  • 1.3. Market Segmentation

2. Executive Summary

3. Global Neurovascular Thrombectomy Devices Market Insights

  • 3.1. Industry Value Chain Analysis
  • 3.2. DROC Analysis
    • 3.2.1. Growth Drivers
      • 3.2.1.1. Rising Prevalence of Stroke
      • 3.2.1.2. Growing Geriatric Population
      • 3.2.1.3. Increasing Awareness and Improved Diagnosis
      • 3.2.1.4. Favorable Reimbursement Policies
    • 3.2.2. Restraints
      • 3.2.2.1. High Cost of Devices
      • 3.2.2.2. Limited Medical Expertise
      • 3.2.2.3. Stringent Regulatory Requirements
    • 3.2.3. Opportunities
      • 3.2.3.1. Technological Advancements
      • 3.2.3.2. Emerging Markets
      • 3.2.3.3. Focus on Minimally Invasive Procedures
    • 3.2.4. Challenges
      • 3.2.4.1. Maintaining Procedural Efficiency
      • 3.2.4.2. Reimbursement Challenges in Many Countries
      • 3.2.4.3. Increased Competition
  • 3.3. Technological Advancements/Recent Developments
  • 3.4. Regulatory Framework
  • 3.5. Porter's Five Forces Analysis
    • 3.5.1. Bargaining Power of Suppliers
    • 3.5.2. Bargaining Power of Buyers
    • 3.5.3. Threat of New Entrants
    • 3.5.4. Threat of Substitutes
    • 3.5.5. Intensity of Rivalry

4. Global Neurovascular Thrombectomy Devices Market: Marketing Strategies

5. Global Neurovascular Thrombectomy Devices Market Overview

  • 5.1. Market Size & Forecast, 2019-2030
    • 5.1.1. By Value (USD Billion)
  • 5.2. Market Share and Forecast
    • 5.2.1. By Device Type
      • 5.2.1.1. Aspiration Devices
      • 5.2.1.2. Stent Retrievers
      • 5.2.1.3. Mechanical Embolus Removal Devices
      • 5.2.1.4. Suction Devices
      • 5.2.1.5. Others
    • 5.2.2. By Indication
      • 5.2.2.1. Ischemic Stroke
      • 5.2.2.2. Hemorrhagic Stroke
      • 5.2.2.3. Others
    • 5.2.3. By End User
      • 5.2.3.1. Hospitals
      • 5.2.3.2. Ambulatory Surgical Centers
      • 5.2.3.3. Specialty Clinics
      • 5.2.3.4. Others
    • 5.2.4. By Region
      • 5.2.4.1. North America
      • 5.2.4.2. Europe
      • 5.2.4.3. Asia Pacific (APAC)
      • 5.2.4.4. Latin America (LATAM)
      • 5.2.4.5. Middle East and Africa (MEA)

6. North America Neurovascular Thrombectomy Devices Market

  • 6.1. Market Size & Forecast, 2019-2030
    • 6.1.1. By Value (USD Billion)
  • 6.2. Market Share & Forecast
    • 6.2.1. By Device Type
    • 6.2.2. By Indication
    • 6.2.3. By End User
    • 6.2.4. By Country
      • 6.2.4.1. United States
      • 6.2.4.1.1. By Device Type
      • 6.2.4.1.2. By Indication
      • 6.2.4.1.3. By End User
      • 6.2.4.2. Canada
      • 6.2.4.2.1. By Device Type
      • 6.2.4.2.2. By Indication
      • 6.2.4.2.3. By End User

7. Europe Neurovascular Thrombectomy Devices Market

  • 7.1. Market Size & Forecast, 2019-2030
    • 7.1.1. By Value (USD Billion)
  • 7.2. Market Share & Forecast
    • 7.2.1. By Device Type
    • 7.2.2. By Indication
    • 7.2.3. By End User
    • 7.2.4. By Country
      • 7.2.4.1. Germany
      • 7.2.4.1.1. By Device Type
      • 7.2.4.1.2. By Indication
      • 7.2.4.1.3. By End User
      • 7.2.4.2. United Kingdom
      • 7.2.4.2.1. By Device Type
      • 7.2.4.2.2. By Indication
      • 7.2.4.2.3. By End User
      • 7.2.4.3. Italy
      • 7.2.4.3.1. By Device Type
      • 7.2.4.3.2. By Indication
      • 7.2.4.3.3. By End User
      • 7.2.4.4. France
      • 7.2.4.4.1. By Device Type
      • 7.2.4.4.2. By Indication
      • 7.2.4.4.3. By End User
      • 7.2.4.5. Spain
      • 7.2.4.5.1. By Device Type
      • 7.2.4.5.2. By Indication
      • 7.2.4.5.3. By End User
      • 7.2.4.6. Belgium
      • 7.2.4.6.1. By Device Type
      • 7.2.4.6.2. By Indication
      • 7.2.4.6.3. By End User
      • 7.2.4.7. Russia
      • 7.2.4.7.1. By Device Type
      • 7.2.4.7.2. By Indication
      • 7.2.4.7.3. By End User
      • 7.2.4.8. The Netherlands
      • 7.2.4.8.1. By Device Type
      • 7.2.4.8.2. By Indication
      • 7.2.4.8.3. By End User
      • 7.2.4.9. Rest of Europe
      • 7.2.4.9.1. By Device Type
      • 7.2.4.9.2. By Indication
      • 7.2.4.9.3. By End User

8. Asia Pacific Neurovascular Thrombectomy Devices Market

  • 8.1. Market Size & Forecast, 2019-2030
    • 8.1.1. By Value (USD Billion)
  • 8.2. Market Share & Forecast
    • 8.2.1. By Device Type
    • 8.2.2. By Indication
    • 8.2.3. By End User
    • 8.2.4. By Country
      • 8.2.4.1. China
      • 8.2.4.1.1. By Device Type
      • 8.2.4.1.2. By Indication
      • 8.2.4.1.3. By End User
      • 8.2.4.2. India
      • 8.2.4.2.1. By Device Type
      • 8.2.4.2.2. By Indication
      • 8.2.4.2.3. By End User
      • 8.2.4.3. Japan
      • 8.2.4.3.1. By Device Type
      • 8.2.4.3.2. By Indication
      • 8.2.4.3.3. By End User
      • 8.2.4.4. South Korea
      • 8.2.4.4.1. By Device Type
      • 8.2.4.4.2. By Indication
      • 8.2.4.4.3. By End User
      • 8.2.4.5. Australia & New Zealand
      • 8.2.4.5.1. By Device Type
      • 8.2.4.5.2. By Indication
      • 8.2.4.5.3. By End User
      • 8.2.4.6. Indonesia
      • 8.2.4.6.1. By Device Type
      • 8.2.4.6.2. By Indication
      • 8.2.4.6.3. By End User
      • 8.2.4.7. Malaysia
      • 8.2.4.7.1. By Device Type
      • 8.2.4.7.2. By Indication
      • 8.2.4.7.3. By End User
      • 8.2.4.8. Singapore
      • 8.2.4.8.1. By Device Type
      • 8.2.4.8.2. By Indication
      • 8.2.4.8.3. By End User
      • 8.2.4.9. Vietnam
      • 8.2.4.9.1. By Device Type
      • 8.2.4.9.2. By Indication
      • 8.2.4.9.3. By End User
      • 8.2.4.10. Rest of APAC
      • 8.2.4.10.1. By Device Type
      • 8.2.4.10.2. By Indication
      • 8.2.4.10.3. By End User

9. Latin America Neurovascular Thrombectomy Devices Market

  • 9.1. Market Size & Forecast, 2019-2030
    • 9.1.1. By Value (USD Billion)
  • 9.2. Market Share & Forecast
    • 9.2.1. By Device Type
    • 9.2.2. By Indication
    • 9.2.3. By End User
    • 9.2.4. By Country
      • 9.2.4.1. Brazil
      • 9.2.4.1.1. By Device Type
      • 9.2.4.1.2. By Indication
      • 9.2.4.1.3. By End User
      • 9.2.4.2. Mexico
      • 9.2.4.2.1. By Device Type
      • 9.2.4.2.2. By Indication
      • 9.2.4.2.3. By End User
      • 9.2.4.3. Argentina
      • 9.2.4.3.1. By Device Type
      • 9.2.4.3.2. By Indication
      • 9.2.4.3.3. By End User
      • 9.2.4.4. Peru
      • 9.2.4.4.1. By Device Type
      • 9.2.4.4.2. By Indication
      • 9.2.4.4.3. By End User
      • 9.2.4.5. Rest of LATAM
      • 9.2.4.5.1. By Device Type
      • 9.2.4.5.2. By Indication
      • 9.2.4.5.3. By End User

10. Middle East and Africa Neurovascular Thrombectomy Devices Market

  • 10.1. Market Size & Forecast, 2019-2030
    • 10.1.1. By Value (USD Billion)
  • 10.2. Market Share & Forecast
    • 10.2.1. By Device Type
    • 10.2.2. By Indication
    • 10.2.3. By End User
    • 10.2.4. By Country
      • 10.2.4.1. Saudi Arabia
      • 10.2.4.1.1. By Device Type
      • 10.2.4.1.2. By Indication
      • 10.2.4.1.3. By End User
      • 10.2.4.2. UAE
      • 10.2.4.2.1. By Device Type
      • 10.2.4.2.2. By Indication
      • 10.2.4.2.3. By End User
      • 10.2.4.3. Qatar
      • 10.2.4.3.1. By Device Type
      • 10.2.4.3.2. By Indication
      • 10.2.4.3.3. By End User
      • 10.2.4.4. Kuwait
      • 10.2.4.4.1. By Device Type
      • 10.2.4.4.2. By Indication
      • 10.2.4.4.3. By End User
      • 10.2.4.5. South Africa
      • 10.2.4.5.1. By Device Type
      • 10.2.4.5.2. By Indication
      • 10.2.4.5.3. By End User
      • 10.2.4.6. Nigeria
      • 10.2.4.6.1. By Device Type
      • 10.2.4.6.2. By Indication
      • 10.2.4.6.3. By End User
      • 10.2.4.7. Algeria
      • 10.2.4.7.1. By Device Type
      • 10.2.4.7.2. By Indication
      • 10.2.4.7.3. By End User
      • 10.2.4.8. Rest of MEA
      • 10.2.4.8.1. By Device Type
      • 10.2.4.8.2. By Indication
      • 10.2.4.8.3. By End User

11. Competitive Landscape

  • 11.1. List of Key Players and Their Offerings
  • 11.2. Global Neurovascular Thrombectomy Devices Market Share Analysis, 2023
  • 11.3. Competitive Benchmarking, By Operating Parameters
  • 11.4. Key Strategic Developments (Mergers, Acquisitions, Partnerships, etc.)

12. Impact of Escalating Geopolitical Tensions on Global Neurovascular Thrombectomy Devices Market

13. Company Profiles (Company Overview, Financial Matrix, Competitive Landscape, Key Personnel, Key Competitors, Contact Address, Strategic Outlook, and SWOT Analysis)

  • 13.1. Acandis GmbH
  • 13.2. Penumbra, Inc.
  • 13.3. Medtronic
  • 13.4. VESALIO, LLC
  • 13.5. Johnson and Johnson
  • 13.6. MicroVention, Inc.
  • 13.7. Phenox GmbH
  • 13.8. Imperative Care, Inc.
  • 13.9. Balt Group
  • 13.10. NeuroVasc Technologies, Inc.
  • 13.11. Baylis Medical Company, Inc.
  • 13.12. Boston Scientific Corporation
  • 13.13. Terumo Corporation
  • 13.14. Spectranetics Corporation
  • 13.15. Edwards Lifesciences Corporation
  • 13.16. Argon Medical Devices, Inc
  • 13.17. Teleflex Incorporated
  • 13.18. Other Prominent Players

14. Key Strategic Recommendations

15. Research Methodology

  • 15.1. Qualitative Research
    • 15.1.1. Primary & Secondary Research
  • 15.2. Quantitative Research
  • 15.3. Market Breakdown & Data Triangulation
    • 15.3.1. Secondary Research
    • 15.3.2. Primary Research
  • 15.4. Breakdown of Primary Research Respondents, By Region
  • 15.5. Assumptions & Limitations